Early experience with CGP 4718 A (Sercloremine), a new selective and reversible MAO-A and 5-HT-uptake inhibitor, in the treatment of depressive patients
A. Delini-Stula, R. Fischbach, F. Gnirss, E. Bures, W. PöldingerVolume:
6
Year:
1985
Language:
english
Pages:
14
DOI:
10.1002/ddr.430060409
File:
PDF, 654 KB
english, 1985